Number of Shares
1.05 Mil
Current Holdings Value*
$35.70 Mil
% of Portfolio
9.17%
Total Estimate Gain
$-21.60 Mil
% of Total Estimate Gain
-28.76%

SR ONE CAPITAL MANAGEMENT, LP's CRISPR Therapeutics AG Holding Summary

As of 2025-03-31, SR ONE CAPITAL MANAGEMENT, LP held 1.05 Mil shares of CRISPR Therapeutics AG(CRSP), totaling $35.70 Mil. This investment constitutes 9.17% of their stock portfolio, and SR ONE CAPITAL MANAGEMENT, LP now holds 1.21% of the outstanding CRISPR Therapeutics AG(CRSP) stock.

The initial trade took place in 2024Q1. And since then SR ONE CAPITAL MANAGEMENT, LP has made 1 purchases of CRSP, at an average price of $71.59, for a total of 1.05 Mil shares. Based on historical transaction data and CRSP's current price of $51.00, SR ONE CAPITAL MANAGEMENT, LP's estimated gain on his CRSP holdings is $-21.60 Mil, reflecting a -28.76% gain to date.

SR ONE CAPITAL MANAGEMENT, LP CRSP ($51.00) Holding Chart

SR ONE CAPITAL MANAGEMENT, LP CRSP ($51.00) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1